Literature DB >> 4378110

Studies of the immunogenicity, communicability and genetic stability of oral poliovaccine administered during the winter.

M Benyesh-Melnick, J L Melnick, W E Rawls, I Wimberly, J B Oro, E Ben-Porath, V Rennick.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1967        PMID： 4378110     DOI： 10.1093/oxfordjournals.aje.a120717

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN： 0002-9262            Impact factor:   4.897


× No keyword cloud information.
  39 in total

1.  Neurovirulence of type 1 polioviruses isolated from sewage in Japan.

Authors:  Hitoshi Horie; Hiromu Yoshida; Kumiko Matsuura; Miwako Miyazawa; Yoshihiro Ota; Takashi Nakayama; Yutaka Doi; So Hashizume
Journal:  Appl Environ Microbiol       Date:  2002-01       Impact factor: 4.792

2.  Circulation of type 1 vaccine-derived poliovirus in the Philippines in 2001.

Authors:  Hiroyuki Shimizu; Bruce Thorley; Fem Julia Paladin; Kerri Anne Brussen; Vicki Stambos; Lilly Yuen; Andi Utama; Yoshio Tano; Minetaro Arita; Hiromu Yoshida; Tetsuo Yoneyama; Agnes Benegas; Sigrun Roesel; Mark Pallansch; Olen Kew; Tatsuo Miyamura
Journal:  J Virol       Date:  2004-12       Impact factor: 5.103

3.  Community circulation patterns of oral polio vaccine serotypes 1, 2, and 3 after Mexican national immunization weeks.

Authors:  Stephanie B Troy; Leticia Ferreyra-Reyes; Chunhong Huang; Clea Sarnquist; Sergio Canizales-Quintero; Christine Nelson; Renata Báez-Saldaña; Marisa Holubar; Elizabeth Ferreira-Guerrero; Lourdes García-García; Yvonne A Maldonado
Journal:  J Infect Dis       Date:  2013-12-23       Impact factor: 5.226

4.  Genotype-specific RNA probes for direct identification of wild polioviruses by blot hybridization.

Authors:  L De; C F Yang; E Da Silva; J Boshell; P Cáceres; J R Gómez; M Pallansch; O Kew
Journal:  J Clin Microbiol       Date:  1997-11       Impact factor: 5.948

5.  Group-specific identification of polioviruses by PCR using primers containing mixed-base or deoxyinosine residue at positions of codon degeneracy.

Authors:  D R Kilpatrick; B Nottay; C F Yang; S J Yang; M N Mulders; B P Holloway; M A Pallansch; O M Kew
Journal:  J Clin Microbiol       Date:  1996-12       Impact factor: 5.948

6.  Environmental surveillance of poliovirus in sewage water around the introduction period for inactivated polio vaccine in Japan.

Authors:  Tomofumi Nakamura; Mitsuhiro Hamasaki; Hideaki Yoshitomi; Tetsuya Ishibashi; Chiharu Yoshiyama; Eriko Maeda; Nobuyuki Sera; Hiromu Yoshida
Journal:  Appl Environ Microbiol       Date:  2015-01-02       Impact factor: 4.792

7.  Evaluation of Proactive and Reactive Strategies for Polio Eradication Activities in Pakistan and Afghanistan.

Authors:  Radboud J Duintjer Tebbens; Kimberly M Thompson
Journal:  Risk Anal       Date:  2018-09-21       Impact factor: 4.000

8.  Modeling population immunity to support efforts to end the transmission of live polioviruses.

Authors:  Kimberly M Thompson; Mark A Pallansch; Radboud J Duintjer Tebbens; Steve G Wassilak; Stephen L Cochi
Journal:  Risk Anal       Date:  2012-09-17       Impact factor: 4.000

9.  Identification of vaccine-related polioviruses by hybridization with specific RNA probes.

Authors:  L De; B Nottay; C F Yang; B P Holloway; M Pallansch; O Kew
Journal:  J Clin Microbiol       Date:  1995-03       Impact factor: 5.948

10.  Evaluation of house-to-house versus fixed-site oral poliovirus vaccine delivery strategies in a mass immunization campaign in Egypt.

Authors:  R W Linkins; E Mansour; O Wassif; M H Hassan; P A Patriarca
Journal:  Bull World Health Organ       Date:  1995       Impact factor: 9.408
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.